BuybackAug 13, 2026, 07:37 AM
Collegium Pharmaceutical Announces $50M Accelerated Share Buyback
AI Summary
Collegium Pharmaceutical, Inc. announced an accelerated share repurchase (ASR) agreement with Jefferies LLC to repurchase $50 million of its common stock. This ASR is part of the $150 million share repurchase program authorized by its Board of Directors in July 2025. The company received an initial delivery of 1,556,420 shares, representing approximately 80% of the total expected under the ASR, with final settlement anticipated by the fourth quarter of 2026.
Key Highlights
- Collegium Pharmaceutical announced a $50 million accelerated share repurchase (ASR) agreement.
- The ASR is part of the $150 million share repurchase program authorized in July 2025.
- Initial delivery of 1,556,420 shares received from Jefferies LLC.
- Initial shares based on the $25.70 closing stock price on August 12, 2026.
- This initial delivery represents approximately 80% of the total shares expected under the ASR.
- Final settlement of the ASR Agreement is expected no later than the fourth quarter of 2026.
- Collegium had approximately 32.5 million shares outstanding as of June 30, 2026.
Price Impact
More from COLL